Orchestra BioMed Holdings, Inc. Stock
Equities
OBIO
US68572M1062
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.81 USD | -5.69% | +13.90% | -45.24% |
Sales 2024 * | 3.31M 4.52M | Sales 2025 * | 3.9M 5.32M | Capitalization | 183M 249M |
---|---|---|---|---|---|
Net income 2024 * | -58M -79.22M | Net income 2025 * | -55M -75.12M | EV / Sales 2024 * | 55.1 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 46.9 x |
P/E ratio 2024 * |
-3.25
x | P/E ratio 2025 * |
-3.27
x | Employees | 56 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.05% |
1 day | -1.96% | ||
1 week | +13.90% | ||
Current month | +13.38% | ||
1 month | +1.42% | ||
3 months | -30.75% | ||
6 months | -4.76% | ||
Current year | -45.24% |
Managers | Title | Age | Since |
---|---|---|---|
Darren Sherman
FOU | Founder | 52 | 23-01-25 |
David Hochman
CEO | Chief Executive Officer | 49 | 23-01-25 |
Andrew Taylor
DFI | Director of Finance/CFO | 53 | 23-06-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Rose
BRD | Director/Board Member | 73 | 23-01-25 |
Eric Fain
BRD | Director/Board Member | 63 | 23-01-25 |
David Hochman
CEO | Chief Executive Officer | 49 | 23-01-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.25% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 4.81 | -5.69% | 8 522 |
24-05-03 | 5.1 | -8.11% | 68,178 |
24-05-02 | 5.55 | +26.14% | 39,728 |
24-05-01 | 4.4 | -0.23% | 44,539 |
24-04-30 | 4.41 | +0.46% | 56,053 |
Delayed Quote Nasdaq, May 06, 2024 at 11:37 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.24% | 183M | |
+8.46% | 218B | |
+7.62% | 184B | |
+13.29% | 135B | |
+0.04% | 62.38B | |
+11.92% | 51.37B | |
+4.81% | 50.9B | |
+1.17% | 40.87B | |
+2.35% | 36.28B | |
+26.28% | 31.88B |
- Stock Market
- Equities
- OBIO Stock